Fourth Quarter and Full Year 2022 Results Conference Call
Receive updates straight into your inbox
Matinas is an emerging clinical-stage biopharmaceutical company, based in Bedminster, New Jersey. Since commencing operations in 2013, we have been working to develop novel, life-changing pharmaceutical products.
What distinguishes us is our targeted approach to therapeutics. Our technologies and products are strategically designed to overcome the limitations associated with existing therapies. Backed with biopharmaceutical expertise and practical knowledge, we can take highly effective drugs and formulate their delivery to be safer, more efficient, and even more clinically effective, with more impact in improving patients’ lives.
Our company is supported by a world-class team of clinical opinion leaders and critical collaborations with industry-leading firms. We all share an unwavering commitment to research and education in the bioscience community – particularly in the fields of lipids and infectious disease. Moving forward, we will continue to expand the depth and breadth of our disruptive platforms.
Matinas BioPharma Holdings, Inc.
1545 Route 206 South
Bedminster, NJ 07921
LHA Investor Relations
T: (310) 691-7100
VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: (212) 828-8436
F: (646) 536-3179